J

Johnson Pharmacare Limited

JOHNPHARMA
Market snapshot · 2026-08-10 19:02 UTC

₹0.46

₹-0.01 (-2.13%)

MARKET CAP

₹25.30 Cr

STOCK P/E

—

52W HIGH

₹0.85

52W LOW

₹0.46

BOOK VALUE

₹0.01

EPS

₹-1.01

ROE

-196.93%

SECTOR

Health Care

DEBT/EQUITY

4,917.72

VOLUME

5.42L

P/B RATIO

57.50x

PEG RATIO

—

Sector

Health Care

Themes

Pharmaceuticals
₹0.79₹0.71₹0.63₹0.55₹0.47VolumeAug '25Sep '25Nov '25Jan '26Mar '26Apr '26Jun '26Aug '26

AI Summary

✦ Clartha

Valuation Metrics

Forward Valuation Outlook

Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.

P/B
Strongly Overvalued

5Y Average

19.51

Current

57.50

Overvalued

58.13

Undervalued

0.60

P/S
Strongly Undervalued

5Y Average

26.53

Current

16.00

Overvalued

33.48

Undervalued

18.70

Peers & Comparison

No peer data available for this company.
WHY THESE PEERS

No sector data available for this company.

Financials

Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.

Latest revenue

₹0.00 CrMar 2026

Latest net profit

₹-56 CrMar 2026

Latest EPS

₹-1.01Mar 2026

Free cash flow

₹-57 CrMar 2026

Performance

Bars show revenue and net profit. The line shows net margin.

Rs crore + margin %
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26-60 Cr-45 Cr-30 Cr-15 Cr0.00 Cr
  • Revenue
  • Net income
  • Net margin %

Earnings

Revenue is shown in crores. EPS is rupees per share.

Rs crore + Rs/share
Q4 '25Q1 '26Q2 '26Q3 '26Q4 '260.00 Cr1.00 Cr2.00 Cr3.00 Cr4.00 Cr₹-1₹-1₹-1₹-0₹0
  • Revenue
  • EPS

Revenue to profit conversion

Bridge from operating numbers to profit for the latest reported period.

Rs crore
RevenueExpensesDepreciationOperatingprofitOther incomeInterestProfitbefore taxTax & otherNet Profit-60 Cr-45 Cr-30 Cr-15 Cr0.00 Cr

Latest reported period: Mar 2026

Debt level and coverage

Debt, cash and free cash flow compared on the same crore scale.

Rs crore
Annual view
Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026-60 Cr-30 Cr0.00 Cr30 Cr60 Cr
  • Debt
  • Free cash flow
  • Cash & equivalents

Results

MetricMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +0000000000000
Expenses +00000000000043
Operating Profit-0-0000-00-0-0-00-0-43
OPM %
Other Income +00000000-0000-13
Interest0000000000000
Depreciation0000000000000
Profit before tax-0-0000-00-0-1-00-0-56
Tax %0%0%0%0%0%0%0%0%
Net Profit +-0-0000-00-0-1-00-0-56
EPS in Rs-0.00-0.000.000.000.00-0.000.00-0.00-0.01-0.000.00-0.00-1.01
Raw PDF

All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).

Shareholding Pattern

HolderJun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Public +99.99%99.99%99.99%99.99%99.99%
Others0.01%0.01%0.01%0.01%0.01%
Jun 2026
Public +
Others

Events Timeline

Board Meeting Intimation for Prior Intimation Of Board Meeting For Approval Of Un-Audited (Standalone) Financial Results For The Quarter Ended On 30Th June, 2026.

Aug 08, 2026PDFCompany Reports Open

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Jul 13, 2026PDFCompany Reports Open

Closure of Trading Window

Jun 26, 2026PDFCompany Reports Open

Submission Of Audited Financials Results Of Jhonson Pharmacare Ltd. For The Quarter And Year Ended On March 31St 2026

Jun 19, 2026PDFCompany Reports Open

Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

Jun 12, 2026PDFCompany Reports Open